Carl T. Foster
Corporate Officer/Principal at Cempra Pharmaceuticals, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christine Ann Miller | F | 48 |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | - |
| Kenneth Touw | M | 76 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | - |
| John Johnson | M | 66 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | 15 years |
| E. Cali Downs | M | - |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | - |
| Gary Horwith | M | - |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | - |
| J. Carl Craft | M | - |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | - |
| Angela Paulovits | F | - |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | 13 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Prabhavathi Fernandes | M | 74 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | 11 years |
| Jane Anderson | F | - |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | - |
| Paul Neff | M | 72 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | 6 years |
| Leanne M. Kiviharju | F | - | - | |
| Jari Kaikkonen | M | - |
Jurilab Oy
 Jurilab Oy Pharmaceuticals: MajorHealth Technology Jurilab Oy provides research and development services. The firm offers pharmacokinetic tests, genotyping services, drug target discovery and Phenotype and target validation services. The company was founded in 1999 and is headquartered in Kuopio, Finland. | 9 years |
| David Oldach | M | 66 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | 6 years |
| David Pereira | M | 65 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | 11 years |
| Drusilla Scott | M | 70 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | 10 years |
| Juha-Matti Aalto | M | - |
Jurilab Oy
Jurilab Oy Pharmaceuticals: MajorHealth Technology Jurilab Oy provides research and development services. The firm offers pharmacokinetic tests, genotyping services, drug target discovery and Phenotype and target validation services. The company was founded in 1999 and is headquartered in Kuopio, Finland. | 8 years |
| Tim Kirk | M | - |
Jurilab Oy
Jurilab Oy Pharmaceuticals: MajorHealth Technology Jurilab Oy provides research and development services. The firm offers pharmacokinetic tests, genotyping services, drug target discovery and Phenotype and target validation services. The company was founded in 1999 and is headquartered in Kuopio, Finland. | 3 years |
| Yvonne Engelen | M | - |
Jurilab Oy
Jurilab Oy Pharmaceuticals: MajorHealth Technology Jurilab Oy provides research and development services. The firm offers pharmacokinetic tests, genotyping services, drug target discovery and Phenotype and target validation services. The company was founded in 1999 and is headquartered in Kuopio, Finland. | - |
| Shishir Sinha | M | 57 | 1 years | |
| Heiner Dreismann | M | 69 | 3 years | |
| David Ray | M | - | - | |
| David Gill | M | 69 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | - |
| Rebecca Maaranto | F | - |
Jurilab Oy
Jurilab Oy Pharmaceuticals: MajorHealth Technology Jurilab Oy provides research and development services. The firm offers pharmacokinetic tests, genotyping services, drug target discovery and Phenotype and target validation services. The company was founded in 1999 and is headquartered in Kuopio, Finland. | - |
| Dov Goldstein | M | 56 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | 4 years |
| Matti Tapani Lappalainen | M | 76 |
Jurilab Oy
Jurilab Oy Pharmaceuticals: MajorHealth Technology Jurilab Oy provides research and development services. The firm offers pharmacokinetic tests, genotyping services, drug target discovery and Phenotype and target validation services. The company was founded in 1999 and is headquartered in Kuopio, Finland. | - |
| Robert Proulx | M | 66 | 4 years | |
| Van N. Schramm | F | - | - | |
| Jukka T. Salonen | M | - |
Jurilab Oy
Jurilab Oy Pharmaceuticals: MajorHealth Technology Jurilab Oy provides research and development services. The firm offers pharmacokinetic tests, genotyping services, drug target discovery and Phenotype and target validation services. The company was founded in 1999 and is headquartered in Kuopio, Finland. | - |
| Rick S. Kent | M | 74 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | - |
| Daniel Burgess | M | 62 | 9 years | |
| Val Buonaiuto | M | - | - | |
| David Ludvigson | M | 74 |
Jurilab Oy
Jurilab Oy Pharmaceuticals: MajorHealth Technology Jurilab Oy provides research and development services. The firm offers pharmacokinetic tests, genotyping services, drug target discovery and Phenotype and target validation services. The company was founded in 1999 and is headquartered in Kuopio, Finland. | - |
| William G. Gerber | M | 77 | 2 years | |
| Frank H. Jellinek | M | 78 | - | |
| Mark Hahn | M | 61 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 27 | 77.14% |
| Finland | 8 | 22.86% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Carl T. Foster
- Personal Network
